Working… Menu

Preventing COVID-19 Complications With Low- and High-dose Anticoagulation (COVID-HEP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04345848
Recruitment Status : Recruiting
First Posted : April 15, 2020
Last Update Posted : December 23, 2020
Information provided by (Responsible Party):
Marc Blondon, University Hospital, Geneva